726 related articles for article (PubMed ID: 33157161)
21. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
[TBL] [Abstract][Full Text] [Related]
22. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
23. Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
Radhakrishnan P; Dabelsteen S; Madsen FB; Francavilla C; Kopp KL; Steentoft C; Vakhrushev SY; Olsen JV; Hansen L; Bennett EP; Woetmann A; Yin G; Chen L; Song H; Bak M; Hlady RA; Peters SL; Opavsky R; Thode C; Qvortrup K; Schjoldager KT; Clausen H; Hollingsworth MA; Wandall HH
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):E4066-75. PubMed ID: 25118277
[TBL] [Abstract][Full Text] [Related]
24. Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter S; Balmaña M; Campos D; Gomes J; Reis CA
Cancer Cell; 2019 Jul; 36(1):6-16. PubMed ID: 31287993
[TBL] [Abstract][Full Text] [Related]
25. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY
OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348
[TBL] [Abstract][Full Text] [Related]
26. How glycosylation affects glycosylation: the role of N-glycans in glycosyltransferase activity.
Mikolajczyk K; Kaczmarek R; Czerwinski M
Glycobiology; 2020 Dec; 30(12):941-969. PubMed ID: 32363402
[TBL] [Abstract][Full Text] [Related]
27. Glycosylation and cancer: moving glycomics to the forefront.
Drake RR
Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
[TBL] [Abstract][Full Text] [Related]
28. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.
Kannagi R; Sakuma K; Miyazaki K; Lim KT; Yusa A; Yin J; Izawa M
Cancer Sci; 2010 Mar; 101(3):586-93. PubMed ID: 20085584
[TBL] [Abstract][Full Text] [Related]
29. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells.
Guo J; Li X; Tan Z; Lu W; Yang G; Guan F
Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275
[TBL] [Abstract][Full Text] [Related]
30. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
[TBL] [Abstract][Full Text] [Related]
31. Sweet systems: technologies for glycomic analysis and their integration into systems biology.
Chen S; Qin R; Mahal LK
Crit Rev Biochem Mol Biol; 2021 Jun; 56(3):301-320. PubMed ID: 33820453
[TBL] [Abstract][Full Text] [Related]
32. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
Guo Y; Jia W; Yang J; Zhan X
Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas9 and glycomics tools for
Gas-Pascual E; Ichikawa HT; Sheikh MO; Serji MI; Deng B; Mandalasi M; Bandini G; Samuelson J; Wells L; West CM
J Biol Chem; 2019 Jan; 294(4):1104-1125. PubMed ID: 30463938
[TBL] [Abstract][Full Text] [Related]
34. When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.
Su H; Wang M; Pang X; Guan F; Li X; Cheng Y
Rev Physiol Biochem Pharmacol; 2021; 180():85-117. PubMed ID: 34031738
[TBL] [Abstract][Full Text] [Related]
35. [Sugars Interfere or Glycomics in the Field of Cancer Biomarkers].
Zahradníková M; Vojtěšek B; Hernychova L
Klin Onkol; 2015; 28 Suppl 2():2S20-5. PubMed ID: 26374154
[TBL] [Abstract][Full Text] [Related]
36. Glycobiology of cellular expiry: Decrypting the role of glycan-lectin regulatory complex and therapeutic strategies focusing on cancer.
Kumar Das A; Ghosh N; Mandal A; Sil PC
Biochem Pharmacol; 2023 Jan; 207():115367. PubMed ID: 36481348
[TBL] [Abstract][Full Text] [Related]
37. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
Sethi MK; Hancock WS; Fanayan S
Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
[TBL] [Abstract][Full Text] [Related]
38. Glycans and glycoproteins as specific biomarkers for cancer.
Kailemia MJ; Park D; Lebrilla CB
Anal Bioanal Chem; 2017 Jan; 409(2):395-410. PubMed ID: 27590322
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic Regulation of Glycosylation in Cancer and Other Diseases.
Indellicato R; Trinchera M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804149
[TBL] [Abstract][Full Text] [Related]
40. Functional roles of N-glycans in cell signaling and cell adhesion in cancer.
Zhao YY; Takahashi M; Gu JG; Miyoshi E; Matsumoto A; Kitazume S; Taniguchi N
Cancer Sci; 2008 Jul; 99(7):1304-10. PubMed ID: 18492092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]